Jack Nathan Medical Corp.
JNHMF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Revenue | $228 | $1,990 | -$4,014 | $5,249 |
| % Growth | -88.6% | 149.6% | -176.5% | – |
| Cost of Goods Sold | $236 | $341 | $1,104 | $963 |
| Gross Profit | -$9 | $1,649 | -$2,910 | $4,286 |
| % Margin | -3.8% | 82.9% | 72.5% | 81.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $355 | $2,335 | $3,643 | $5,128 |
| SG&A Expenses | $429 | $2,423 | $3,646 | $5,238 |
| Sales & Mktg Exp. | $74 | $88 | $3 | $110 |
| Other Operating Expenses | $45 | $58 | -$9,934 | $335 |
| Operating Expenses | $474 | $2,480 | -$6,288 | $5,573 |
| Operating Income | -$482 | -$831 | $1,170 | -$1,287 |
| % Margin | -212% | -41.8% | -29.1% | -24.5% |
| Other Income/Exp. Net | $233 | $4 | $1,065 | -$509 |
| Pre-Tax Income | -$249 | -$827 | $2,235 | -$1,796 |
| Tax Expense | $0 | $156 | $36 | $0 |
| Net Income | -$42 | -$983 | $12,194 | -$1,796 |
| % Margin | -18.5% | -49.4% | -303.8% | -34.2% |
| EPS | -0.003 | -0.011 | 0.025 | -0.021 |
| % Growth | 74.3% | -144.8% | 222.3% | – |
| EPS Diluted | -0.003 | -0.011 | 0.024 | -0.021 |
| Weighted Avg Shares Out | 14,719 | 87,106 | 501,840 | 87,102 |
| Weighted Avg Shares Out Dil | 87,434 | 87,099 | 335 | 96,102 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1,053 | $0 |
| Interest Expense | $10 | $11 | $0 | $558 |
| Depreciation & Amortization | $16 | $24 | $99 | $249 |
| EBITDA | -$460 | -$796 | $1,293 | -$1,022 |
| % Margin | -202.2% | -40% | -32.2% | -19.5% |